Enzo Biochem at the end of the month will present for the first time peer-reviewed data on detection of hepatitis C virus using its new AmpiProbe nucleic acid amplification chemistry, the company said today.
Dako, Amgen Ink CDx Deal for Undisclosed Oncologic
Dako and Amgen announced they will partner to develop a companion diagnostic for an undisclosed oncology drug that Amgen is currently advancing in clinical trials.
NEW YORK (GenomeWeb News) – The Enzo Clinical Labs division of Enzo Biochem has received approval from the New York State Department of Health to market GeneNews' ColonSentry test to residents of the state.
Enzo Life Sciences has filed three separate lawsuits against Roche, Life Technologies, and Gen-Probe claiming that various nucleic acid probe-based research and diagnostics products from those companies infringe a patent owned by Enzo.